SSG
SGHT icon

Summit Securities Group’s Sight Sciences SGHT Stock Holding History

Summit Securities Group’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.8K Buy
+2,863
New +$15.4K ﹤0.01% 657

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Summit Securities Group's SGHT Position: Q1 2026 in Review

Summit Securities Group opened a new position in Sight Sciences (SGHT) in Q1 2026: 2,863 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #657 among its holdings.

114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Summit Securities Group held 2,863 shares of Sight Sciences worth $10.8K as of Q1 2026.
  • Sight Sciences was a new Summit Securities Group position in Q1 2026.
  • Sight Sciences made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #657 holding.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.